QLQianqian Liu

Qianqian Liu

*This is an algorithmically generated author record based on publicly available information.

Qianqian Liu has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AI-based strategies for diagnosis and therapeutic discovery in pulmonary fibrosis

    by Yue Lin, Qianqian Liu, Xiangyi Lei, Huiyu Cao, Pengmian Feng, Yuemei Wang, Dan Sun, Guang Xin, Sanyin Zhang, Wei Chen

  • Open Access

    A novel homozygous HPS4 mutation in Hermansky–Pudlak syndrome: case report and literature review

    by Qianqian Liu, Wenqi Qing, Shanshan Guo, Yongsheng Wang, Yunfeng Chen, Jie Liu

    Hermansky–Pudlak syndrome (HPS) is a rare autosomal recessive disorder caused by defects in lysosome-related organelles (LROs). Eleven HPS subtypes have been identified, each associated with mutations in distinct genes, with HPS-4 being among the rarer forms. Here, we present a 38-year-old Chinese woman with oculocutaneous albinism (OCA), bleeding tendency, and progressive pulmonary fibrosis, ultimately diagnosed with HPS through platelet transmission electron microscopy. The patient received nintedanib, an antifibrotic agent, which appeared to stabilize pulmonary function for approximately 18 months. Genetic testing revealed a novel homozygous splice site variant in HPS4 (NM_022081.6 c.1713+1delG), predicted to result in splice disruption and nonsense-mediated mRNA decay. Based on in silico analysis, the variant was considered pathogenic. To contextualize this case, we reviewed all published HPS4-related cases and identified 51 reported patients carrying 37 unique mutations, including 16 nonsense, 8 frameshift, 7 splice-site, 5 missense, and 1 gross insertion variant. Our findings broaden the mutational spectrum of HPS4 and support the utility of nintedanib in managing HPS-associated interstitial lung disease. It also underscores the potential for pharmacologic intervention to alter the disease trajectory in HPS, particularly in resource-limited settings where lung transplantation is not widely accessible.


  • Open Access

    Brain-derived extracellular vesicles promote bone-fat imbalance in Alzheimer's disease

    by Xixi Liu, Chunyuan Chen, Yaling Jiang, Meidan Wan, Bin Jiao, Xinxin Liao, Shanshan Rao, Chungu Hong, Qijie Yang, Yuan Zhu, et al.

    Inadequate osteogenesis and excessive adipogenesis of bone marrow mesenchymal stem cells (BMSCs) are key factors in the pathogenesis of osteoporosis. Patients with Alzheimer's disease (AD) have a higher incidence of osteoporosis than healthy adults, but the underlying mechanism is not clear. Here, we show that brain-derived extracellular vesicles (EVs) from adult AD or wild-type mice can cross the blood-brain barrier to reach the distal bone tissue, while only AD brain-derived EVs (AD-B-EVs) significantly promote the shift of the BMSC differentiation fate from osteogenesis to adipogenesis and induce a bone-fat imbalance. MiR-483-5p is highly enriched in AD-B-EVs, brain tissues from AD mice, and plasma-derived EVs from AD patients. This miRNA mediates the anti-osteogenic, pro-adipogenic, and pro-osteoporotic effects of AD-B-EVs by inhibiting Igf2. This study identifies the role of B-EVs as a promoter of osteoporosis in AD by transferring miR-483-5p.


  • Open Access

    Identifying Demographic and Disease Related Differences in Hispanic Vs Non-Hispanic Patients with Classical Hodgkin Lymphoma

    by Abhishek Pandya, Supreet Kaur, Qianqian Liu, Joel E Michalek, Adolfo Enrique Diaz Duque


  • Open Access

    New diagnosis for hepatocellular carcinoma via hsa_circ_0097009

    by Xue Wang, Tingwei Peng, Limin Xu, Zuohua Lu, Qianqian Liu, Beibei Li, Yufang Wang, Xinghui Liu

    Background Although circular RNAs take a key part in the regulation of cancer, its role in the diagnosis and prognosis of hepatocellular carcinoma (HCC) still unclear. This study investigated the diagnostic and prognostic usefulness of hsa_circ_0097009 in HCC. Methods qRT-PCR assay was performed to detect the presence of hsa_circ_0097009 in plasma collected from 30 HCC patients and 30 healthy controls. Receiver operating characteristic (ROC) curve, Cox regression, and Kaplan–Meier curve analyses were applied to evaluate the clinical diagnostic and prognostic values of hsa_circ_0097009. Results The experimental data suggested that hsa_circ_0097009 expression of HCC plasma and cell lines is upregulated. The plasma hsa_circ_0097009 level of HCC patients was linked to tumor diameter (P = 0.026) and alpha-fetoprotein (AFP) expression level (P = 0.019). In addition, the plasma level of hsa_circ_0097009 decreased markedly after surgery to remove the tumor. Moreover, the level of plasma of hsa_circ_0097009 in HCC patients was increased compared with healthy controls (P < 0.0001) and hepatitis B patients. ROC curve reflected that the area under the curve (AUC) of plasma hsa_circ_0097009 to distinguish HCC from healthy controls and hepatitis B patients were 0.9368 (95 percent CI = 0.8874–0.9862) and 0.9067 (95 percent CI = 0.8439–0.9695), respectively, with the same sensitivity 0.9779 and the same specificity 0.6889. Furthermore, the AUC value of hsa_circ_0097009 combined with AFP for distinguishing HCC from healthy controls was 0.9822 (95 percent CI = 0.9682–0.9961), with the sensitivity 0.9889 and specificity 0.667. The plasma hsa_circ_0097009 low expression group had a considerably longer overall survival (OS) than the high expression group. Conclusion The study suggests that hsa_circ_0097009 could be used as a new potential biomarker in diagnoses and prognoses of HCC patients.

  • Open Access

    Stepwise lactate kinetics in critically ill patients: prognostic, influencing factors, and clinical phenotype

    by Bo Tang, Longxiang Su, Dongkai Li, Ye Wang, Qianqian Liu, Guangliang Shan, Yun Long, Dawei Liu, Xiang Zhou

    To investigate the optimal target e of lactate kinetics at different time during the resuscitation, the factors that influence whether the kinetics achieve the goals, and the clinical implications of different clinical phenotypes. Patients with hyperlactatemia between May 1, 2013 and December 31, 2018 were retrospectively analyzed. Demographic data, basic organ function, hemodynamic parameters at ICU admission (T0) and at 6 h, 12 h, 24 h, 48 h, and 72 h, arterial blood lactate and blood glucose levels, cumulative clinical treatment conditions at different time points and final patient outcomes were collected. A total of 3298 patients were enrolled, and the mortality rate was 12.2%. The cutoff values of lactate kinetics for prognosis at 6 h, 12 h, 24 h, 48 h, and 72 h were 21%, 40%, 57%, 66%, and 72%. The APACHE II score, SOFA score, heart rate (HR), and blood glucose were risk factors that correlated with whether the lactate kinetics attained the target goal. Based on the pattens of the lactate kinetics, eight clinical phenotypes were proposed. The odds ratios of death for clinical phenotypes VIII, IV, and II were 4.39, 4.2, and 5.27-fold of those of clinical phenotype I, respectively. Stepwise recovery of lactate kinetics is an important resuscitation target for patients with hyperlactatemia. The APACHE II score, SOFA score, HR, and blood glucose were independent risk factors that influenced achievement of lactate kinetic targets. The cinical phenotypes of stepwise lactate kinetics are closely related to the prognosis.


  • Is ethnicity related to the distribution of lymphomas by subtype in a majority minority Hispanic community?

    by Juan Garza, Adolfo Enrique Diaz Duque, Michelle Janania Martinez, Prathibha Surapaneni, Tyler William Snedden, Sushanth Kakarla, Jeremy Rawlings, David Gregorio, Snegha Ananth, Joel Michalek, et al.

    E20083 Background: Non-Hodgkin Lymphoma (NHL) continues to be in the top 10 of all cancer related deaths. Discrepancies exist among world regions in lymphoma subtype incidence, with a percentage of DLBCL being higher in Latin America versus Nordic countries. T cell lymphomas (TCL) are reported to be more common in east Asia than in the Western hemisphere.The geographic differences in distribution along with under representation of ethnic minorities across all lymphoma subtypes, establish the basis of our analysis at the only NCI-designated cancer center within a Hispanic (H) predominant patient population. We aim to describe our population diagnosed with Hodgkin Lymphoma (HL) and NHL and compare to known overall global and USA statistics. Methods: Observational study, retrospectively analyzed patients with diagnosis of Lymphoma (HL and NHL). The patients received care at UT Health San Antonio, the biggest Hispanic serving Academic Institution in South Texas, between 2008-2018. Key variables included age, gender, race/ethnicity, stage, treatment received, vitality at 3 and 5 years. Continuously distributed outcomes were summarized with the mean and standard deviation and categorical outcomes were summarized with frequencies and percentages. Primary end point was to characterize distribution of HL and NHL by subtypes in our Cancer Center and compare to North American and overall global distribution. Results: A total of 685 patients with lymphoma were identified. Of the NHL subtypes; DLBCL was the most common identified (209, 31%), (FL) was the most common indolent lymphoma (IL) among all demographic groups (123, 26%), followed by HL (116, 17%) which was more common among non-Hispanic (NH) subgroup (73, 63% vs 42, 36%). Among the TCL, CTCL – Mycosis fungoides was the most common subtype (18, 35%) followed by ALK negative ALCL (12, 24%). Incidence by Gender: The percentage of males (M) was slightly higher vs. females (F) in all subtype lymphoma diagnoses, M (352, 51%), F (333, 49%). M had a higher incidence in DLBCL (108, 52% vs 101, 48%), BL (9, 69% vs 4, 31%), and HL (67, 58% vs 49, 44%). Incidence by Race: Total lymphoid neoplasm rates were higher for H (383, 57%) than NH (293, 43%), other (1, 0.2%), not specified (5, 1%). H had a higher incidence in all subtype lymphomas except for Nodular lymphocyte predominant HL (5, 63% vs 3, 37%). Conclusions: Our Hispanic Hispanic Serving Academic Institution, the distribution of lymphomas doesn’t change when compared with previous reported data. Our population and distribution of lymphoma subtypes are similar to global and USA data.

  • Rs7574865 polymorphism of STAT4 and risk of anti-tuberculosis drug-induced hepatotoxicity in Chinese Han

    by Guo Chen, Wei Mao, Shou-Quan Wu, Yu Wang, Gui-Yi Ji, Miao-Miao Zhang, Qian-Qian Liu, Jian-Qing He